Lecanemab and donanemab effects lasting over three years, new treatments, trials of home injections and blood tests for ...

Alzheimer’s Research UK shared with the government what we need to see from the Spending Review 2025 to deliver better outcomes for people affected by dementia.

Mary, an Alzheimer’s Research UK supporter, discovered a deep connection with gardening after her husband Richard was ...

We look at what two new studies reveal about the impact of air pollution on brain health, and explore what we can do to ...

For the millions of people affected by dementia and Parkinson’s, better treatments can’t come soon enough. Current options are limited and don’t stop the conditions getting worse. Developing new ...

People with early-stage Alzheimer’s disease in England and Wales will not get NHS access to the first two medicines proven to slow down the disease, after the National Institute for Health and Care ...

We have produced several illustrations and infographics of concepts in dementia research, making them more accessible to non-scientific audiences. Please feel free to use them: Sign up to receive our ...

Walk, jog or runJoin our advent challenge, and complete 25 miles throughout December. Whether you walk, jog or run, make every mile count this Christmas and raise funds for vital dementia research.

People with Parkinson’s are up to six times more likely to develop dementia. This is called Parkinson’s disease dementia.

Study finds people with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower risk of dementia.

Dementia devastates the lives of everyone it touches, but our analysis shows that women are bearing a disproportionate weight of the impact.